Literature DB >> 2408757

Control of cell locomotion: perturbation with an antibody directed against specific glycoproteins.

S L Goodman, H P Vollmers, W Birchmeier.   

Abstract

A murine monoclonal antibody, SLOW-1, was selected, which inhibits the locomotion of chick embryo fibroblasts (the immunizing cells) in tissue culture. The antibody, an IgM, cross-reacts in locomotion assays with a number of tumor and untransformed cells, and on fixed and permeabilized cells binds 1-5 X 10(5) target sites with an affinity of 10(-8) M. The antigen can be extracted from cells with isotonic buffers containing EGTA, binds to Concanavalin A, and when analyzed on SDS gels by immunoblotting, two major antigenic glycoproteins are detected at 57 kd (isoelectric point, 5.1) and at 44 kd (isoelectric point, 5.4). The antigenic site involves galactosyl or mannosyl residues, or both, within a complex, N-linked carbohydrate tree. The possible contribution of the SLOW-1 antigen to a common control system of locomotion operating over the cell surface is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408757     DOI: 10.1016/s0092-8674(85)80083-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  15 in total

1.  Localization of the PP2A B56gamma regulatory subunit at the Golgi complex: possible role in vesicle transport and migration.

Authors:  Akihiko Ito; Yu-ichiro Koma; Miwa Sohda; Kenji Watabe; Teruaki Nagano; Yoshio Misumi; Hiroshi Nojima; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}.

Authors:  Feng Guan; Lana Schaffer; Kazuko Handa; Sen-Itiroh Hakomori
Journal:  FASEB J       Date:  2010-08-18       Impact factor: 5.191

3.  Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells.

Authors:  Hernán G Farina; Débora R Bublik; Daniel F Alonso; Daniel E Gomez
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

4.  Inhibitory action of transforming growth factor beta on endothelial cells.

Authors:  G Müller; J Behrens; U Nussbaumer; P Böhlen; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 5.  The invasive phenotypes.

Authors:  M M Mareel; F M Van Roy; P De Baetselier
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

6.  Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1.

Authors:  Shangyang She; Boying Xu; Min He; Xiuwan Lan; Qiuyan Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-07-11

7.  Nucleokinesis: distinct pattern of cell translocation in response to an autocrine motility factor-like substance or fibronectin.

Authors:  J Klominek; K G Sundqvist; K H Robért
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction.

Authors:  J Klominek; B Baskin; D Hauzenberger
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

9.  Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

Authors:  S Silletti; S Paku; A Raz
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

10.  Loquat (Eriobotrya japonica) extracts suppress the adhesion, migration and invasion of human breast cancer cell line.

Authors:  Min-Sook Kim; Mi-Kyoung You; Dong-Young Rhuy; Yung-Jae Kim; Hum-Young Baek; Hyeon-A Kim
Journal:  Nutr Res Pract       Date:  2009-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.